Shirin Regali, CFA, a sell-side analyst covering the biotech sector, issues a "buy" recommendation for Bio Heal Inc. based on insights from unaffiliated industry experts. She distributes this recommendation to her clients but not to the public. Has Regali most likely violated the Standard relating to material nonpublic information?